NCT01999725View on ClinicalTrials.gov

Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Safety in Normal Volunteers
Interventions
DRUG

EDP-788

EDP-788 Capsules and matching placebo capsules. EDP-788 Liquid Suspension and matching placebo. All interventions are given as single doses

DRUG

Placebo

Matching placebo capsules or matching suspension

Trial Locations (1)

78744

PPD Phase I Clinic, Austin

Sponsors
All Listed Sponsors
lead

Enanta Pharmaceuticals, Inc

INDUSTRY

NCT01999725 - Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788 | Biotech Hunter | Biotech Hunter